Not Tagged
Orum Therapeutics
[]
orum therapeutics unveils new program at aacr 2023, highlighting cbl-b inhibitor-pd-1 conjugate, and presents new data supporting clinical development of two gspt1 programs 
Pharmaceutical News - Direct Information